13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
SANOFI SA INHABER EO 2 920657 Frankfurt 87,060 19.06.24 16:22:26 -0,810 -0,92% 86,870 86,980 87,820 87,060
REGENERON PHARMAC.DL-,001 881535 Frankfurt 966,200 20.06.24 08:07:06 +2,400 +0,25% 966,200 972,200 966,200 963,800

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH